Updates in Management of Large Hemispheric Infarct

Overview

Journal Semin Neurol

Specialty Neurology

Date 2024 May 17

PMID 38759959

Authors

Charlene J Ong

Stefanos Chatzidakis

Jimmy J Ong

Steven Feske

Affiliations

Soon will be listed here.

Abstract

This review delves into updates in management of large hemispheric infarction (LHI), a condition affecting up to 10% of patients with supratentorial strokes. While traditional management paradigms have endured, recent strides in research have revolutionized the approach to acute therapies, monitoring, and treatment. Notably, advancements in triage methodologies and the application of both pharmacological and mechanical abortive procedures have reshaped the acute care trajectory for patients with LHI. Moreover, ongoing endeavors have sought to refine strategies for the optimal surveillance and mitigation of complications, notably space-occupying mass effect, which can ensue in the aftermath of LHI. By amalgamating contemporary guidelines with cutting-edge clinical trial findings, this review offers a comprehensive exploration of the current landscape of acute and ongoing patient care for LHI, illuminating the evolving strategies that underpin effective management in this critical clinical domain.

References

McKeown M, Prasad A, Kobsa J, Top I, Snider S, Kidwell C . Midline Shift Greater than 3 mm Independently Predicts Outcome After Ischemic Stroke. Neurocrit Care. 2021; 36(1):46-51. PMC: 8813904. DOI: 10.1007/s12028-021-01341-x. View

Jovin T, Li C, Wu L, Wu C, Chen J, Jiang C . Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion. N Engl J Med. 2022; 387(15):1373-1384. DOI: 10.1056/NEJMoa2207576. View

Berkhemer O, Fransen P, Beumer D, van den Berg L, Lingsma H, Yoo A . A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2014; 372(1):11-20. DOI: 10.1056/NEJMoa1411587. View

Huttner H, Schwab S . Malignant middle cerebral artery infarction: clinical characteristics, treatment strategies, and future perspectives. Lancet Neurol. 2009; 8(10):949-58. DOI: 10.1016/S1474-4422(09)70224-8. View

Cheng Y, Wu S, Wang Y, Song Q, Yuan R, Wu Q . External Validation and Modification of the EDEMA Score for Predicting Malignant Brain Edema After Acute Ischemic Stroke. Neurocrit Care. 2019; 32(1):104-112. DOI: 10.1007/s12028-019-00844-y. View

Wu S, Wang Y, Yuan R, Guo F, Yang D, Li Z . Predicting the emergence of malignant brain oedema in acute ischaemic stroke: a prospective multicentre study with development and validation of predictive modelling. EClinicalMedicine. 2023; 59:101977. PMC: 10154953. DOI: 10.1016/j.eclinm.2023.101977. View

Jovin T, Chamorro A, Cobo E, de Miquel M, Molina C, Rovira A . Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015; 372(24):2296-306. DOI: 10.1056/NEJMoa1503780. View

Dennis M, Sandercock P, Graham C, Forbes J, Smith J . The Clots in Legs Or sTockings after Stroke (CLOTS) 3 trial: a randomised controlled trial to determine whether or not intermittent pneumatic compression reduces the risk of post-stroke deep vein thrombosis and to estimate its cost-effectiveness. Health Technol Assess. 2015; 19(76):1-90. PMC: 4782814. DOI: 10.3310/hta19760. View

Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D . Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008; 359(13):1317-29. DOI: 10.1056/NEJMoa0804656. View

10.

Sheth K, Elm J, Molyneaux B, Hinson H, Beslow L, Sze G . Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol. 2016; 15(11):1160-9. DOI: 10.1016/S1474-4422(16)30196-X. View

11.

Hofmeijer J, van der Worp H, Kappelle L, Amelink G, Algra A, van Zandvoort M . Cognitive outcome of survivors of space-occupying hemispheric infarction. J Neurol. 2013; 260(5):1396-403. DOI: 10.1007/s00415-012-6810-1. View

12.

Saver J, Goyal M, Bonafe A, Diener H, Levy E, Pereira V . Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015; 372(24):2285-95. DOI: 10.1056/NEJMoa1415061. View

13.

Cook A, Jones G, Hawryluk G, Mailloux P, McLaughlin D, Papangelou A . Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients. Neurocrit Care. 2020; 32(3):647-666. PMC: 7272487. DOI: 10.1007/s12028-020-00959-7. View

14.

Ma H, Campbell B, Parsons M, Churilov L, Levi C, Hsu C . Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke. N Engl J Med. 2019; 380(19):1795-1803. DOI: 10.1056/NEJMoa1813046. View

15.

Ropper A, Shafran B . Brain edema after stroke. Clinical syndrome and intracranial pressure. Arch Neurol. 1984; 41(1):26-9. DOI: 10.1001/archneur.1984.04050130032017. View

16.

Bendszus M, Fiehler J, Subtil F, Bonekamp S, Aamodt A, Fuentes B . Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial. Lancet. 2023; 402(10414):1753-1763. DOI: 10.1016/S0140-6736(23)02032-9. View

17.

Wu S, Yuan R, Wang Y, Wei C, Zhang S, Yang X . Early Prediction of Malignant Brain Edema After Ischemic Stroke. Stroke. 2018; 49(12):2918-2927. DOI: 10.1161/STROKEAHA.118.022001. View

18.

Goostrey K, Muehlschlegel S . Prognostication and shared decision making in neurocritical care. BMJ. 2022; 377:e060154. DOI: 10.1136/bmj-2021-060154. View

19.

Albers G, Marks M, Kemp S, Christensen S, Tsai J, Ortega-Gutierrez S . Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018; 378(8):708-718. PMC: 6590673. DOI: 10.1056/NEJMoa1713973. View

20.

de Assis Aquino Gondim F, Aiyagari V, Shackleford A, Diringer M . Osmolality not predictive of mannitol-induced acute renal insufficiency. J Neurosurg. 2005; 103(3):444-7. DOI: 10.3171/jns.2005.103.3.0444. View